Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
ICON announced the appointment of Julie O’Neill as a non-executive director.
read more
ICON plc announced the completion of its acquisition of PRA Health Sciences. The combined company will retain the name ICON and will bring together 38,000 employees across 47 countries, creating the world’s most advanced healthcare intelligence and ...
read more
Thursday, October 24, 2019
ICON has acquired Symphony Clinical Research, a provider of at-home patient and site support services.
read more
Tuesday, February 28, 2012
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of PriceSpective LLC, a global leader in value strategy consulting. The acquisition ...
read more
ICON announced that it has acquired the Mapi Group.
read more
ICON has acquired a majority shareholding in MeDiNova Research, a site network with research sites in key markets in Europe and Africa.
read more
ICIG announced today changes in the management of CordenPharma, its pharmaceutical contract manufacturing business.
read more
Tuesday, September 21, 2021
Ichor Therapeutics is now known as Ichor Life Sciences. The new name reflects Ichor Life Sciences’ emphasis on delivering premium preclinical contract research and custom programs in discovery through pharmacology from its R&D facilities in LaFayette...
read more
Thursday, January 25, 2024
Ichor Life Sciences, a full-service, end-to-end contract research organization (CRO) announced the expansion of Ichor Clinical’s services to Australia, Europe, and the United Kingdom.
read more
Tuesday, December 21, 2021
Ichor Life Sciences, a preclinical contract research organization offering services in discovery through pharmacology, has formally completed the acquisition of Woodland Biosciences, Inc. The in vivo services for the study of metabolic diseases and ...
read more
Monday, November 20, 2023
Ichor Life Sciences, a comprehensive contract research organization (CRO), has introduced Ichor Clinical Trial Services, expanding its capabilities to cater to the needs of biotechnology and pharmaceutical clients throughout the entire drug ...
read more
Tuesday, November 26, 2019
ValGenesis has announced an Iceland-based biotech firm has selected ValGenesis's VLMS as their platform for validation process management across multiple sites.
read more
Tuesday, September 03, 2019
IceCure Medical has announced an exclusive distribution agreement with global medical company, Terumo Corporation.
read more
The ICDD and the CCDC have announced a new partnership, which will allow greater utility and insights in the development of new drugs and materials.
read more
iCardiac Technologies, Inc., a scientific leader in the conduct of cardiac safety assessments, today announced it is providing industry-wide access to its pivotal dataset as part of an effort announced by the Cardiac Safety Research Consortium to ...
read more